Safety and Pharmacokinetics of LopinavirRitonavir Oral Solution in Preterm and Term Infants Starting before 3 Months of Age

dc.article.end-page360en
dc.article.start-page355en
dc.citation.doi10.1097/INF.0000000000004243en
dc.contributor.authorA Bekkeren
dc.contributor.authorJ Yangen
dc.contributor.authorJ Wangen
dc.contributor.authorM. F Cottonen
dc.contributor.authorFirdose Nakwaen
dc.contributor.authorAvyi Violarien
dc.contributor.authorE et alen
dc.date.accessioned2025-03-17T10:16:07Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn0891-3668en
dc.identifier.urihttps://hdl.handle.net/10539/44344
dc.journal.titleSafety and Pharmacokinetics of LopinavirRitonavir Oral Solution in Preterm and Term Infants Starting before 3 Months of Ageen
dc.journal.volume43en
dc.publisherLIPPINCOTT WILLIAMS & WILKINSen
dc.titleSafety and Pharmacokinetics of LopinavirRitonavir Oral Solution in Preterm and Term Infants Starting before 3 Months of Ageen
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
396.62 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client